French pharma giant to market Dengue fever vaccine
A vaccine for dengue fever will soon be on the market, according to Sanofi Pasteur which has opened a factory to produce the medicine near the French city of Lyon. The French pharmaceutical company is targeting the 400 million cases it estimates to exist worldwide.
Sanofi has invested 350 million euros and built a factory, which already employs 150 people, in the town of Neuville-sur-Saône, despite the fact that the drug is still under development.
The vaccine is expected to be on the market in 2015, although production for testing should start next January.
British pharmaceutical company GlaxoSmithKline is working on a vaccine against malaria, which kills more than 650,000 people every year.